These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6430610)
1. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; van Es LA Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610 [TBL] [Abstract][Full Text] [Related]
2. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Vanes LA Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604 [TBL] [Abstract][Full Text] [Related]
3. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Vanes LA; Cats A Immunology; 1980 Jul; 40(3):417-24. PubMed ID: 6903557 [TBL] [Abstract][Full Text] [Related]
4. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. Daha MR; van Es LA J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579 [TBL] [Abstract][Full Text] [Related]
5. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. Daha MR; van Es LA J Immunol; 1979 Mar; 122(3):801-5. PubMed ID: 448075 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5. Strunk RC; Giclas PC J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706 [No Abstract] [Full Text] [Related]
7. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. Halbwachs L; Leveillé M; Lesavre P; Wattel S; Leibowitch J J Clin Invest; 1980 Jun; 65(6):1249-56. PubMed ID: 6902727 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway. Hiramatsu M; Tsokos GC Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058 [TBL] [Abstract][Full Text] [Related]
9. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610 [TBL] [Abstract][Full Text] [Related]
10. Relationship between the component and regulatory proteins of the classical pathway C3 convertase. Welch TR; Forristal J; Beischel L J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565 [TBL] [Abstract][Full Text] [Related]
11. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related]
12. The role of carbohydrate in the structure and function of nephritic factor. Scott DM; Amos N; Bartolotti SR Clin Exp Immunol; 1981 Oct; 46(1):120-9. PubMed ID: 6802534 [TBL] [Abstract][Full Text] [Related]
13. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase. Burge J; Nicholson-Weller A; Austen KF J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916 [TBL] [Abstract][Full Text] [Related]
14. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus. Gharavi AE; Elkon KB; Schifferli JA; Hughes GR J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885 [TBL] [Abstract][Full Text] [Related]
15. Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. Arvieux J; Roussel B; Ponard D; Colomb MG Clin Exp Immunol; 1991 Jun; 84(3):466-71. PubMed ID: 2044227 [TBL] [Abstract][Full Text] [Related]
16. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Daha MR; Van Es LA Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073 [No Abstract] [Full Text] [Related]
17. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
18. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600 [TBL] [Abstract][Full Text] [Related]
19. Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity. Spitzer RE; Stitzel AE; Tsokos GC J Immunol; 1992 Jan; 148(1):137-41. PubMed ID: 1727863 [TBL] [Abstract][Full Text] [Related]
20. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. Anderson CL; Stillman WS J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]